Testing effectiveness (Phase 2)Study completedNCT03181893What this trial is testingA Study In Adults With Moderate To Severe DermatomyositisWho this might be right forDermatomyositis Pfizer 75
Early research (Phase 1)Looking for participantsNCT07715136What this trial is testingBCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory MyopathyWho this might be right forInflammatory Myopathy iCell Gene Therapeutics 10
Testing effectiveness (Phase 2)Study completedNCT05192200What this trial is testingAn Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent StudyWho this might be right forDermatomyositis Pfizer 24
Not applicableUnknownNCT01482494What this trial is testingDetection of Pompe Disease in Adult Patients With Myopathies of Uncertain Origin or With Asymptomatic Hyper-CK-emiaWho this might be right forPompe Disease Jordi Perez Lopez 50
Early research (Phase 1)Study completedNCT00533091What this trial is testingEvaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or PolymyositisWho this might be right forDERMATOMYOSITIS OR POLYMYOSITIS MedImmune LLC 51
Testing effectiveness (Phase 2)Study completedNCT01572844What this trial is testingTopical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated CalcinosisWho this might be right forCalcinosis Alison Ehrlich 3
Not applicableUnknownNCT06004817What this trial is testingEvaluation of Severity in Juvenile and Adult-onset DermatomyositisWho this might be right forDermatomyositis Central Hospital, Nancy, France 200
Testing effectiveness (Phase 2)WithdrawnNCT02980198What this trial is testingStudy of IFN-K in DermatomyositisWho this might be right forDermatomyositis Neovacs
Not applicableLooking for participantsNCT04402086What this trial is testingRheumatology Patient Registry and BiorepositoryWho this might be right forRheumatic DiseasesAdult Onset Still DiseaseAnkylosing Spondylitis+17 more Yale University 5,000
Large-scale testing (Phase 3)Study completedNCT02971683What this trial is testingTrial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory MyopathyWho this might be right forPolymyositisDermatomyositisAutoimmune Necrotizing Myopathy+2 more Bristol-Myers Squibb 149
Large-scale testing (Phase 3)Study completedNCT05523167What this trial is testingInvestigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.Who this might be right forActive Idiopathic Inflammatory MyopathyMyositisDermatomyositis+3 more argenx 265
Testing effectiveness (Phase 2)Looking for participantsNCT07111065What this trial is testingFAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)Who this might be right forDermatomyositis (DM)Juvenile Dermatomyositis (JDM) National Institute of Environmental Health Sciences (NIEHS) 3,000
Large-scale testing (Phase 3)Ended earlyNCT04999020What this trial is testingRavulizumab Versus Placebo in Adult Participants With DermatomyositisWho this might be right forDermatomyositis Alexion Pharmaceuticals, Inc. 38
Large-scale testing (Phase 3)Ended earlyNCT04044690What this trial is testingEvaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)Who this might be right forDermatomyositis CSL Behring 134
Testing effectiveness (Phase 2)Study completedNCT05695950What this trial is testingA Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With DermatomyositisWho this might be right forDermatomyositis Lakefront Biotherapeutics NV 40
Large-scale testing (Phase 3)Study completedNCT05437263What this trial is testingInvestigate the Efficacy and Safety of Brepocitinib in Adults With DermatomyositisWho this might be right forDermatomyositis Priovant Therapeutics, Inc. 241
Early research (Phase 1)Looking for participantsNCT06298019What this trial is testingStudy of KYV-101 Anti-CD19 CAR T Therapy in Adult DermatomyositisWho this might be right forDermatomyositis Stanford University 21
Not applicableLooking for participantsNCT07377058What this trial is testingRCT of Tocilizumab for Anti-MDA5+DMWho this might be right forDermatomyositis Peking Union Medical College Hospital 110
Large-scale testing (Phase 3)Enrolling By InvitationNCT05979441What this trial is testingAssess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory MyopathyWho this might be right forMyositisActive Idiopathic Inflammatory MyopathyDermatomyositis+3 more argenx 240
Early research (Phase 1)Looking for participantsNCT07085104What this trial is testingInvestigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseWho this might be right forSystemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis Allogene Therapeutics 66